To carry out their activities, Research Teams of the Frédéric Joliot Institute for Life Sciences have developed high-profile technological platforms in many areas : biomedical imaging, structural biology, metabolomics, High-Throughput screening, level 3 microbiological safety laboratory...
Within the Institute, the "Funding Research and Technology Transfer" team is at your disposal to identify the scientists and the skills you need to set up a joint project, to define the terms of a collaboration contract or study.
Whether you are an academic, a SME or an industrialist, our team informs and advices you about the possibilities of consortium assembly, technology transfer, patent licensing or use of our platforms.
The team is also at the disposal of the researchers of the institute to accompany them in achieving their valorization objectives.
All the news of the Institute of life sciences Frédéric Joliot
The "Funds Research and Technology Transfer" team is present to help researchers achieve these goals. On specifically patents, our institute has a portfolio of 48 patent families for which the "Funds Research and Technology Transfer" team is at the disposal of companies interested in an operating commercial license.
We are looking for manufacturers to whom we can entrust our patents and know-how. Prospecting actions are regularly carried out by our team in exhibitions, convention or internal and external seminars.If you are a manufacturer seeking a license from one of the laboratories of our institute, please contact us.
Many researchers, engineers and technicians of the Institute, have a long experience of collaborations with leading pharmaceutical, chemical, biotechnology and diagnostics industrials. This experience is reflected in the number of industrial laboratories working with our teams and also by the desire to offer a recognized unit. In this regard, the Pharmacology and Immuno Analysis unit is ISO9001certified since December 2014.
These industrial collaborations undertaken by the Institute teams, allow us to work on common subjects, after having defined the objectives and contracted collaborations. Thus, these collaborations allow reaching faster R&D projects, co-publishing results to file patents and to consider future developments, some towards promising diagnostic tests or future drugs.
The IBITECS teams with expertise and/or labeled platform are open to studies, in the form of research benefits. We have already a strong and significant experience in the following areas:
Some collaborations are realized through hosting in our institute premises, in companies or academic research units :
Recently, the creation of a joint laboratory (the Labcom ARCHIPEX established in November 2014) has formalized a long collaboration between the team of the institute led by Maite Paternostre and the pharmaceutical company IPSEN. This joint laboratory aims the development of new pharmaceutical forms self-assembled for a sustained release of peptide drugs.
The IBITECS has a corporate creation culture mainly in the fields of pharmacology. Recently the Profilomics Company was created from the activities of the Pharmacology and Immunoassay Unit in mass spectrometry applied to metabolomics.
This culture is used by the "Funds Research and Technology Transfer" team to promote collaboration between industrials and research teams.
CEA is a French government-funded technological research organisation in four main areas: low-carbon energies, defense and security, information technologies and health technologies. A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world.